Yu M - Search Results

1

Physiologically-based pharmacokinetic modeling to inform dosing regimens and routes of administration of rifampicin and colistin combination against Acinetobacter baumannii.

Zhang J, Song C, Wu M, Yue J, Zhu S, Zhu P, Oo C, Schlender JF, Lv Z, Zhu Y, Sy SKB, Yu M. Zhang J, et al. Among authors: yu m. Eur J Pharm Sci. 2023 Jun 1;185:106443. doi: 10.1016/j.ejps.2023.106443. Epub 2023 Apr 10. Eur J Pharm Sci. 2023. PMID: 37044198 Free article.

2

Identification and analysis of an impurity inducing clinical adverse effect in anti-adhesion carboxymethyl chitosan products.

Yu MM, Jiang TF, Wang YH, Wang DY, Lv ZH. Yu MM, et al. J Pharm Biomed Anal. 2013 Nov;85:21-7. doi: 10.1016/j.jpba.2013.06.023. Epub 2013 Jun 28. J Pharm Biomed Anal. 2013. PMID: 23872212

3

Largazole pharmacokinetics in rats by LC-MS/MS.

Yu M, Salvador LA, Sy SK, Tang Y, Singh RS, Chen QY, Liu Y, Hong J, Derendorf H, Luesch H. Yu M, et al. Mar Drugs. 2014 Mar 20;12(3):1623-40. doi: 10.3390/md12031623. Mar Drugs. 2014. PMID: 24658499 Free PMC article.

4

Pharmacokinetics of para-aminosalicylic acid in HIV-uninfected and HIV-coinfected tuberculosis patients receiving antiretroviral therapy, managed for multidrug-resistant and extensively drug-resistant tuberculosis.

de Kock L, Sy SK, Rosenkranz B, Diacon AH, Prescott K, Hernandez KR, Yu M, Derendorf H, Donald PR. de Kock L, et al. Among authors: yu m. Antimicrob Agents Chemother. 2014 Oct;58(10):6242-50. doi: 10.1128/AAC.03073-14. Epub 2014 Aug 11. Antimicrob Agents Chemother. 2014. PMID: 25114132 Free PMC article. Clinical Trial.

5

Population Pharmacokinetic and Covariate Analysis of Apatinib, an Oral Tyrosine Kinase Inhibitor, in Healthy Volunteers and Patients with Solid Tumors.

Yu M, Gao Z, Dai X, Gong H, Zhang L, Chen X, Zhong DF, Sy SK. Yu M, et al. Clin Pharmacokinet. 2017 Jan;56(1):65-76. doi: 10.1007/s40262-016-0427-y. Clin Pharmacokinet. 2017. PMID: 27379402 Clinical Trial.

6

Glycosaminoglycan from Apostichopus japonicus induces immunomodulatory activity in cyclophosphamide-treated mice and in macrophages.

Wang H, Xu L, Yu M, Wang Y, Jiang T, Yang S, Lv Z. Wang H, et al. Among authors: yu m. Int J Biol Macromol. 2019 Jun 1;130:229-237. doi: 10.1016/j.ijbiomac.2019.02.093. Epub 2019 Feb 20. Int J Biol Macromol. 2019. PMID: 30797007

7

Glycosaminoglycan from Apostichopus japonicus inhibits hepatic glucose production via activating Akt/FoxO1 and inhibiting PKA/CREB signaling pathways in insulin resistant hepatocytes.

Chen Y, Liu H, Wang Y, Yang S, Yu M, Jiang T, Lv Z. Chen Y, et al. Among authors: yu m. Food Funct. 2019 Nov 1;10(11):7565-7575. doi: 10.1039/c9fo01444f. Epub 2019 Nov 5. Food Funct. 2019. PMID: 31687719

8

Glycosaminoglycan from Apostichopus japonicus Improves Glucose Metabolism in the Liver of Insulin Resistant Mice.

Chen Y, Wang Y, Yang S, Yu M, Jiang T, Lv Z. Chen Y, et al. Among authors: yu m. Mar Drugs. 2019 Dec 18;18(1):1. doi: 10.3390/md18010001. Mar Drugs. 2019. PMID: 31861309 Free PMC article.

9

Simultaneous determination of FL118 and W34 in rat Blood by LC-MS/MS: Application to pharmacokinetic studies.

Feng K, Zhang J, Zhang Y, Jiang T, Lv Z, Yu M. Feng K, et al. Among authors: yu m. Biomed Chromatogr. 2020 Nov;34(11):e4944. doi: 10.1002/bmc.4944. Epub 2020 Jul 21. Biomed Chromatogr. 2020. PMID: 32639034

10

LC-MS/MS Determination of Apigenin in Rat Plasma and Application to Pharmacokinetic Study.

Zhu S, Zhang J, Lv Z, Yu M. Zhu S, et al. Among authors: yu m. Curr Pharm Biotechnol. 2021;22(2):274-280. doi: 10.2174/1389201021666200807113144. Curr Pharm Biotechnol. 2021. PMID: 32767914

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15,740 results

Search Page